Schedule 13G ownership disclosure

RedHill Biopharma Ltd.

Security class unavailable · CUSIP: M8208M118

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-004545
Form type
SC 13G/A
Filer
Ibex Investors LLC
CIK
CIK 1531964
Filed
Jan 15, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub